USPTOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The US trademark MABLAUNCH was filed as Word mark on 07/18/2011 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 08/14/2012.
The current status of the mark is "CANCELLED - SECTION 8".
| Trademark form | Word mark |
| File reference | 85373673 |
| Register number | 4189253 |
| Application date | July 18, 2011 |
| Publication date | May 29, 2012 |
| Entry date | August 14, 2012 |
Trademark owner
54 rue La Boétie
75008 Paris
FR
75008 Paris
FR
Trademark representatives
goods and services
1
(Based on 44(e)) Monoclonal antibodies, cells and cell-lines for scientific, laboratory or medical research and for the use in the manufacture of pharmaceuticals, biochemistry, molecular biology
40
(Based on Use in Commerce) Custom manufacture of biochemical, and cell-based assays on behalf of others; custom production of reagents, cells and cell lines on behalf of others; custom manufacture of transgenic products, namely, pharmaceuticals, biopharmaceuticals and proteins; treatment of cells, chemical solutions, DNA delivery vehicles, proteinaceous molecules and nucleic acids for use in the preparation of pharmaceuticals and/or genetic biochemicals and/or molecular biology
42
(Based on 44(e)) Scientific services, namely, research in the medical and biochemical field, namely, the examination and testing of genes, pharmaceutical and biochemical semi-finished products, test systems for monoclonal antibodies, cells and cell-lines; scientific research concerning culture media for cultivation of monoclonal antibodies, cells and cell-lines, genetically modified material for use in medicines, genetherapy, gene banks and diagnostic purposes, and for the development of medicines, genetherapy, gene banks, diagnostic purposes, biochemistry and molecular biology
ID: 1385373673